(GIL) Gildan Activewear - Overview
Sector: Consumer Cyclical | Industry: Apparel Manufacturing | Exchange: NYSE (USA) | Market Cap: 10.086m USD | Total Return: 26.4% in 12m
Avg Trading Vol: 72.0M USD
Peers RS (IBD): 55.4
EPS Trend: -10.7%
Qual. Beats: 0
Rev. Trend: 30.1%
Qual. Beats: 0
Gildan Activewear Inc. (GIL) is a Canadian apparel manufacturer. The company produces a range of activewear, hosiery, and underwear products.
GILs product portfolio includes T-shirts, fleece, and polos under brands like Gildan and American Apparel. They also offer socks through brands such as GoldToe and Peds, and underwear under the Gildan brand. The apparel manufacturing sector is characterized by a global supply chain and competitive pricing.
The company distributes its products to wholesale channels, including screenprinters, and directly to retailers across North America, Europe, Asia-Pacific, and Latin America. This business model combines wholesale distribution with direct retail sales. For further detailed analysis, investors can explore Gildans financial performance on ValueRay.
Founded in 1946, Gildan Activewear Inc. operates within the Apparel, Accessories & Luxury Goods GICS Sub Industry.
- Cotton price fluctuations impact manufacturing costs
- Activewear demand drives wholesale revenue
- North American retail sales influence profitability
- International expansion opens new market opportunities
| Net Income: 399.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA -4.87 > 1.0 |
| NWC/Revenue: 67.94% < 20% (prev 31.22%; Δ 36.72% < -1%) |
| CFO/TA 0.06 > 3% & CFO 590.0m > Net Income 399.7m |
| Net Debt (4.59b) to EBITDA (744.6m): 6.16 < 3 |
| Current Ratio: 2.11 > 1.5 & < 3 |
| Outstanding Shares: last quarter (160.2m) vs 12m ago 3.78% < -2% |
| Gross Margin: 30.99% > 18% (prev 0.31%; Δ 3.07k% > 0.5%) |
| Asset Turnover: 51.34% > 50% (prev 88.03%; Δ -36.70% > 0%) |
| Interest Coverage Ratio: 4.76 > 6 (EBITDA TTM 744.6m / Interest Expense TTM 125.8m) |
| A: 0.24 (Total Current Assets 4.70b - Total Current Liabilities 2.23b) / Total Assets 10.45b |
| B: 0.11 (Retained Earnings 1.17b / Total Assets 10.45b) |
| C: 0.08 (EBIT TTM 599.1m / Avg Total Assets 7.08b) |
| D: 0.50 (Book Value of Equity 3.44b / Total Liabilities 6.89b) |
| Altman-Z'' Score: 3.01 = A |
| DSRI: 1.58 (Receivables 953.9m/542.4m, Revenue 3.63b/3.27b) |
| GMI: 0.99 (GM 30.99% / 30.59%) |
| AQI: 2.45 (AQ_t 0.39 / AQ_t-1 0.16) |
| SGI: 1.11 (Revenue 3.63b / 3.27b) |
| TATA: -0.02 (NI 399.7m - CFO 590.0m) / TA 10.45b) |
| Beneish M-Score: -1.64 (Cap -4..+1) = CCC |
Over the past week, the price has changed by -3.32%, over one month by -16.31%, over three months by -10.65% and over the past year by +26.38%.
- StrongBuy: 6
- Buy: 6
- Hold: 1
- Sell: 0
- StrongSell: 0
| Wallstreet Target Price | 83.1 | 49.3% |
| Analysts Target Price | 83.1 | 49.3% |
P/E Forward = 13.0039
P/S = 2.7868
P/B = 2.9105
P/EG = 0.6679
Revenue TTM = 3.63b USD
EBIT TTM = 599.1m USD
EBITDA TTM = 744.6m USD
Long Term Debt = 3.86b USD (from longTermDebt, last quarter)
Short Term Debt = 508.8m USD (from shortTermDebt, last quarter)
Debt = 4.87b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.59b USD (from netDebt column, last quarter)
Enterprise Value = 14.68b USD (10.09b + Debt 4.87b - CCE 283.9m)
Interest Coverage Ratio = 4.76 (Ebit TTM 599.1m / Interest Expense TTM 125.8m)
EV/FCF = 30.40x (Enterprise Value 14.68b / FCF TTM 482.8m)
FCF Yield = 3.29% (FCF TTM 482.8m / Enterprise Value 14.68b)
FCF Margin = 13.28% (FCF TTM 482.8m / Revenue TTM 3.63b)
Net Margin = 11.00% (Net Income TTM 399.7m / Revenue TTM 3.63b)
Gross Margin = 30.99% ((Revenue TTM 3.63b - Cost of Revenue TTM 2.51b) / Revenue TTM)
Gross Margin QoQ = 28.19% (prev 33.67%)
Tobins Q-Ratio = 1.40 (Enterprise Value 14.68b / Total Assets 10.45b)
Interest Expense / Debt = 0.85% (Interest Expense 41.4m / Debt 4.87b)
Taxrate = 7.82% (4.41m / 56.4m)
NOPAT = 552.3m (EBIT 599.1m * (1 - 7.82%))
Current Ratio = 2.11 (Total Current Assets 4.70b / Total Current Liabilities 2.23b)
Debt / Equity = 1.37 (Debt 4.87b / totalStockholderEquity, last quarter 3.56b)
Debt / EBITDA = 6.16 (Net Debt 4.59b / EBITDA 744.6m)
Debt / FCF = 9.51 (Net Debt 4.59b / FCF TTM 482.8m)
Total Stockholder Equity = 1.97b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.65% (Net Income 399.7m / Total Assets 10.45b)
RoE = 20.31% (Net Income TTM 399.7m / Total Stockholder Equity 1.97b)
RoCE = 10.27% (EBIT 599.1m / Capital Employed (Equity 1.97b + L.T.Debt 3.86b))
RoIC = 11.56% (NOPAT 552.3m / Invested Capital 4.78b)
WACC = 6.28% (E(10.09b)/V(14.96b) * Re(8.94%) + D(4.87b)/V(14.96b) * Rd(0.85%) * (1-Tc(0.08)))
Discount Rate = 8.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -3.44%
[DCF] Terminal Value 84.16% ; FCFF base≈430.8m ; Y1≈394.1m ; Y5≈349.9m
[DCF] Fair Price = 27.16 (EV 9.62b - Net Debt 4.59b = Equity 5.03b / Shares 185.2m; r=6.28% [WACC]; 5y FCF grow -10.66% → 3.0% )
EPS Correlation: -10.67 | EPS CAGR: -49.06% | SUE: -4.0 | # QB: 0
Revenue Correlation: 30.08 | Revenue CAGR: 5.63% | SUE: 0.57 | # QB: 0
EPS next Quarter (2026-06-30): EPS=1.25 | Chg7d=+0.000 | Chg30d=-0.072 | Revisions Net=-2 | Analysts=9
EPS current Year (2026-12-31): EPS=4.31 | Chg7d=-0.001 | Chg30d=-0.210 | Revisions Net=-12 | Growth EPS=+22.9% | Growth Revenue=+69.6%
EPS next Year (2027-12-31): EPS=5.37 | Chg7d=-0.006 | Chg30d=-0.060 | Revisions Net=-3 | Growth EPS=+24.5% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: -0.50 (1 Up / 3 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.2% (Discount Rate 8.9% - Earnings Yield 4.7%)
[Growth] Growth Spread = +75.2% (Analyst 79.5% - Implied 4.2%)